GlassScriptPhysician profile
Robert J Krug
NPI 1215935168
$13,507.87
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $556 · 2021: $332 · 2022: $125 · 2023: $74.91 · 2024: $84.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $159.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12,074.68 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $287.15 | 2019 | |
| Abbvie INC. | $246.19 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $210.44 | 2021 | |
| Medtronic USA, INC. | $200.00 | 2019 | |
| Genentech USA, INC. | $146.48 | 2019 | |
| Alexion Pharmaceuticals, INC. | $126.00 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $84.23 | 2024 | Dysport |
| Penumbra, INC. | $74.91 | 2023 | Penumbra System |
| Janssen Pharmaceuticals, INC | $23.67 | 2020 | |
| Merz North America, INC. | $22.90 | 2020 | |
| Hydrocision, INC. | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Krug listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.